JP2023524788A5 - - Google Patents
Info
- Publication number
- JP2023524788A5 JP2023524788A5 JP2022567414A JP2022567414A JP2023524788A5 JP 2023524788 A5 JP2023524788 A5 JP 2023524788A5 JP 2022567414 A JP2022567414 A JP 2022567414A JP 2022567414 A JP2022567414 A JP 2022567414A JP 2023524788 A5 JP2023524788 A5 JP 2023524788A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain
- specific binding
- amino acid
- binding molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2006629.6A GB202006629D0 (en) | 2020-05-05 | 2020-05-05 | Specific binding molecules |
| GB2006629.6 | 2020-05-05 | ||
| PCT/EP2021/061731 WO2021224261A1 (en) | 2020-05-05 | 2021-05-04 | Soluble tors and fusions to anti-cd3 recognising kras g12d for the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524788A JP2023524788A (ja) | 2023-06-13 |
| JP2023524788A5 true JP2023524788A5 (https=) | 2024-01-30 |
| JP7682927B2 JP7682927B2 (ja) | 2025-05-26 |
Family
ID=71080372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567414A Active JP7682927B2 (ja) | 2020-05-05 | 2021-05-04 | 特異的結合性分子 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230348595A1 (https=) |
| EP (1) | EP4146257A1 (https=) |
| JP (1) | JP7682927B2 (https=) |
| CN (1) | CN115867310A (https=) |
| AU (1) | AU2021267361A1 (https=) |
| CA (1) | CA3181362A1 (https=) |
| GB (1) | GB202006629D0 (https=) |
| WO (1) | WO2021224261A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201901305D0 (en) * | 2019-01-30 | 2019-03-20 | Immunocore Ltd | Specific binding molecules |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| CN115850444B (zh) * | 2022-09-15 | 2025-01-28 | 重庆医科大学 | Tcr或其抗原结合片段及其应用 |
| CN118812698A (zh) * | 2023-04-19 | 2024-10-22 | 香雪生命科学技术(广东)有限公司 | 一种识别kras突变的高亲和力t细胞受体及其应用 |
| CN118852403A (zh) * | 2023-04-26 | 2024-10-29 | 北京鼎成肽源生物技术有限公司 | 靶向kras突变的tcr分子和细胞及其应用 |
| CN118852452A (zh) * | 2023-04-28 | 2024-10-29 | 北京鼎成肽源生物技术有限公司 | 靶向kras g12突变的tcr分子和细胞及其应用 |
| CN120157754A (zh) * | 2023-12-14 | 2025-06-17 | 新景智源生物科技(苏州)有限公司 | Kras_g12d突变抗原特异性tcr及其与cd8共表达重定向cd4 t细胞 |
| WO2025189363A1 (zh) * | 2024-03-12 | 2025-09-18 | 广州医科大学 | 一种t细胞受体(tcr)及其用途 |
| CN120647748B (zh) * | 2025-05-16 | 2026-03-06 | 浙江大学 | 一种活性提升的tcr及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998039482A1 (en) | 1997-03-07 | 1998-09-11 | Sunol Molecular Corporation | Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |
| ATE533784T1 (de) | 1997-10-02 | 2011-12-15 | Altor Bioscience Corp | Lösliche, einzelkettige proteine des t- zellrezeptors |
| MXPA02005559A (es) | 1999-12-06 | 2004-09-10 | Univ Illinois | Proteinas de tcr de alta afinidad y metodos. |
| EP1259601A2 (en) | 2000-02-22 | 2002-11-27 | Ahuva Nissim | Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| IL160359A0 (en) | 2001-08-31 | 2004-07-25 | Avidex Ltd | Soluble t cell receptor |
| CA2501870C (en) | 2002-10-09 | 2013-07-02 | Avidex Limited | Single chain recombinant t cell receptors |
| PT1558643E (pt) | 2002-11-09 | 2009-08-24 | Immunocore Ltd | Apresentação de um receptor das células t |
| GB0908613D0 (en) | 2009-05-20 | 2009-06-24 | Immunocore Ltd | T Cell Reseptors |
| GB0911566D0 (en) * | 2009-07-03 | 2009-08-12 | Immunocore Ltd | T cell receptors |
| GB201223172D0 (en) | 2012-12-21 | 2013-02-06 | Immunocore Ltd | Method |
| GB201314404D0 (en) * | 2013-08-12 | 2013-09-25 | Immunocore Ltd | T Cell Receptors |
| GB201505305D0 (en) * | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| US11827688B2 (en) | 2016-06-02 | 2023-11-28 | Immunocore Limited | Dosing regimen for GP100-specific TCR—anti-CD3 SCFV fusion protein |
| LT3428194T (lt) | 2017-07-14 | 2021-12-10 | Immatics Biotechnologies Gmbh | Pagerinta dvejopo savitumo polipeptido molekulė |
-
2020
- 2020-05-05 GB GBGB2006629.6A patent/GB202006629D0/en not_active Ceased
-
2021
- 2021-05-04 EP EP21723720.5A patent/EP4146257A1/en active Pending
- 2021-05-04 JP JP2022567414A patent/JP7682927B2/ja active Active
- 2021-05-04 CA CA3181362A patent/CA3181362A1/en active Pending
- 2021-05-04 CN CN202180042266.0A patent/CN115867310A/zh active Pending
- 2021-05-04 US US17/998,032 patent/US20230348595A1/en active Pending
- 2021-05-04 AU AU2021267361A patent/AU2021267361A1/en active Pending
- 2021-05-04 WO PCT/EP2021/061731 patent/WO2021224261A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524788A5 (https=) | ||
| JP2023522799A5 (https=) | ||
| JP2020530762A5 (https=) | ||
| RU2762255C2 (ru) | Т-клеточные рецепторы | |
| RU2742691C2 (ru) | Cd3-связывающий домен | |
| JP2021524267A5 (https=) | ||
| JP2019023184A5 (https=) | ||
| HRP20211744T1 (hr) | Poboljšana molekula polipeptida dvostruke specifičnosti | |
| IL308831A (en) | T cell receptors | |
| JP2022542543A5 (https=) | ||
| JP2021524268A5 (https=) | ||
| JP7682927B2 (ja) | 特異的結合性分子 | |
| JP2021520831A5 (https=) | ||
| JP2024532485A5 (https=) | ||
| JP2018502050A5 (https=) | ||
| CN116789820A (zh) | 一种新型免疫调节剂的开发和应用 | |
| WO2018156735A1 (en) | Bispecific antibody for cancer immunotherapy | |
| JP2022009816A5 (https=) | ||
| JP2019503686A5 (https=) | ||
| JP2024518378A5 (https=) | ||
| IL292358A (en) | specific binding molecules | |
| JP2024509910A5 (https=) | ||
| JP2021531834A5 (https=) | ||
| JP2025504909A5 (https=) | ||
| IL321809A (en) | Binding molecules against a piwil1 peptide-hla complex |